Sean H. Lim

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

Journal: Cancer research

Published: January 16, 2026

Case Report: Improvement from no light perception after radiotherapy and surgical debulking for orbital Rosai-Dorfman disease.

Case Report: Improvement from no light perception after radiotherapy and surgical debulking for orbital Rosai-Dorfman disease.

Journal: Frontiers in ophthalmology

Published: September 22, 2025

Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies.

Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: September 08, 2025

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 29, 2025

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Journal: Nature communications

Published: December 10, 2024

A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.

A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.

Journal: Cancer immunology research

Published: November 04, 2024

Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.

Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.

Journal: Lancet (London, England)

Published: September 11, 2024

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Journal: The Lancet. Rheumatology

Published: November 16, 2023

Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 08, 2023

Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY.

Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY.

Journal: The Lancet. Rheumatology

Published: April 26, 2023

Two approaches to tackling COVID-19 in patients with blood cancer.

Two approaches to tackling COVID-19 in patients with blood cancer.

Journal: Nature cancer

Published: February 01, 2023

Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate.

Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate.

Journal: PloS one

Published: January 20, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026